The FDA historically has not really stepped over the line to tell the doctor that they cannot compound, he said
DiMarchi, who thinks there should be human trials testing GLP-1s for concussions
This makes it particularly effective in tissues like the stomach and intestines , which regenerate rapidly but are vulnerable to chemical, dietary, and inflammatory damage
adults currently take a GLP-1 for weight loss (up from 3 percent in 2024 and 8 percent in 2025) 15 percent have used a GLP-1 medication for weight loss at some point 68 percent of current users take brand-name medications such as Ozempic, Wegovy, or Zepbound 19 percent take compounded or custom-mixed GLP-1 versions not approved by the FDA 91 percent of Americans now know GLP-1 drugs can be used for weight loss (up from 80 percent in 2024) The Medicare GLP-1 Bridge, administered by the Centers for Medicare and Medicaid Services (CMS), is a demonstration program operating outside the standard Part D benefit
Liraglutide is another long-acting GLP-1RA that is administered once daily
Triggers pituitary GH release without significant cortisol, prolactin, or aldosterone elevation